<DOC>
	<DOCNO>NCT02688296</DOCNO>
	<brief_summary>The objective post-market clinical study evaluate efficacy outcomes complication rate patient receive Fibulock™ Intramedullary Nail .</brief_summary>
	<brief_title>Effectiveness Of The Fibulock Intramedullary Nail</brief_title>
	<detailed_description>This retrospective/prospective , multi-site observational study , design evaluate clinical outcome complication rate subject previously implant Fibulock™ intramedullary nail . Patients screen eligibility subgroupings . Informed consent obtain meet screen criterion interested participate study . Sites ask enroll subject accord past treatment , Fibulock™ intramedullary nail unstable fibula fracture . The site enroll subject study base inclusion/exclusion criterion . Patient pre-operative , intra-operative post-operative record review retrospectively . Once enrol , subject undergo evaluation fracture outcome complete VAS pain score , SF-12 , Foot Function Index 26 week 52 week post-treatment .</detailed_description>
	<mesh_term>Fractures , Bone</mesh_term>
	<criteria>An unstable fibula fracture . Must le 31 week postimplantation Must receive surgical treatment Fibulock Intramedullary Nail unstable fibula fracture Male female great equal 18 year age skeletally mature . Able understand requirement study , provide write informed consent comply study protocol Ability understand provide write authorization use disclosure personal health information . Patients implanted Sonoma Fibulock IM Nail</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>